Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of June 11, 2025 • 2:00 AM ET
Date/Time | Source | News Release |
---|---|---|
03/18/2025 07:30 AM EDT | PR Newswire | Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes |
03/13/2025 07:30 AM EDT | PR Newswire | Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting |
03/05/2025 07:30 AM EST | PR Newswire | Virax Biolabs to Present at 19th World Immune Regulation Meeting |
02/25/2025 07:00 AM EST | PR Newswire | Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy |
As of June 11, 2025 • 2:00 AM ET
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.